Representing a domestic private equity fund and a listed company in the joint acquisition of a business unit in France and Poland owned by a global Fortune 500 automotive manufacturer engaged in the development and manufacture of powertrain sensors, actuators and electronic turbochargers;
Representing a Fortune 500 company owned by the Chinese central government to acquire 100% shares of a leading international company with over 150 years of history in the auto parts industry. The target company is based in Germany with subsidiaries in Czech, US, Mexico, South Africa, UK, PRC and etc.;
Representing a well-known Chinese listed company in the auto parts industry to acquire 100% shares of a leading German company in the lightweight auto parts industry;
Representing a leading domestically listed company to acquire a leading international company specializing in rubber parts production related to automotive power and battery cooling systems. The target company is based in Germany with multiple subsidiaries in the world;
Representing a listed Chinese company in its acquisition of a leading Korean manufacturer of automotive steering wheels and a controlling interest in certain of its subsidiaries in China;
Representing a large state-owned enterprise in China to acquire a prestigious UK company in the global remanufacturing industry. The target company has six subsidiaries in the UK, the US, HK, PRC and etc.;
Representing a famous listed company in China to acquire the automotive pipe joint products’ business as well as assets of a multinational group in France, PRC, Mexico, Switzerland and other countries;
Representing a leading privately owned enterprise in China in the mold R&D and manufacturing industry to acquire assets of a French enterprise;
Representing a listed company in China to acquire 100% shares of a leading American environmental testing company. The target company owns more than 20 laboratories, nearly 40 service centers, and more than 33,000 laboratory licenses in the world. The transaction constituted a major asset reorganization of the listed company;
Representing a Chinese listed company to acquire an international municipal engineering design company based in Spain. The target company has more than ten subsidiaries within Spain as well as outside of Spain;
Representing a domestic listed company dedicated to the R&D and manufacture of APIs and intermediates in the acquisition of a 100% equity interest in a CRO, CDMO company located in the United States;
Representing a leading domestic listed company in the industry in its acquisition of 100% of a subsidiary owned by a global Fortune 500 multinational pharmaceutical company engaged in the production of APIs (divesting part of its R&D assets);
Representing a listed Chinese company in the acquisition of the API assets of a global Fortune 500 multinational pharmaceutical company located at its Mengěs plant in Slovenia;
Representing a domestic buyer in the acquisition of 100% equity interest in an industry leading company owned by a French multinational group of companies engaged in the R&D and manufacturing of salicylic acid series chemicals, pharmaceutical intermediates and other fine chemicals;
Representing a well-known domestic listed company in the acquisition of an API production site of a multinational company located in Hangzhou, China;
Representing a leading listed company in China to acquire 100% shares of a worldwide well-known company in the storage industry. The target company is based in Spain with subsidiaries in 19 countries of the world;
Representing a Chinese listed company in its acquisition of a US multinational company manufacturing industrial yarns and cord fabric. The target company having entities and plants in the US, Mexico, Germany and France;
Representing a Fortune 500 financial group to acquire a securities company in China;
Representing a well-known logistics enterprise in the US to acquire assets of a privately owned logistics company in China;
Representing a US generator manufacturer to acquire assets of a listed company in China;
Representing a leading group in China’s energy industry to acquire multiple hydroelectric projects in Malaysia and Myanmar;
Representing a private enterprise in China to acquire all shares of a high-tech company in Israel;
Representing a well-known medical equipment company in China to acquire an orthopedic medical equipment company, and to assist the multi-round financing of the company;
Representing a well-known listed Chinese company in the sale of its subsidiaries and assets abroad to a multinational group of companies and in the restructuring of its offshore equity and debt;
Representing the actual controller of an outdoor advertising company in China to sell its holdings of all shares to a multinational group;
Representing a chemical enterprise in China to sell its majority ownership to a multinational group;
Representing the beneficial owner of a Chinese color printing and packaging company in the sale of its shareholding to a multinational company;
Representing a World 500 multinational group to set up a fund management company with a securities company in China in the form of a joint venture, and to conduct asset restructuring;
Representing multiple of the world’s top tier car manufacturing companies to set up car financing companies in the form of WFOE or JV in China, and to assist the follow-up asset restructuring and acquisition;
Representing a large company owned by the Chinese central government dealing with matters in relation to the transfer of its equity interest in a joint venture company with a Russian bulk metals company;
Representing a state-owned bank dealing with matters in relation to the share deal and syndicated loan financing arrangement of a large Russian energy company.